November 02, 2025

Get In Touch

Abbott India's Goa Plant Director Munish Prashar to resign

Mumbai:Abbott India has announced the resignation of Munish Prashar, Plant Director – Goa. His departure will be effective from the close of business hours on October 31, 2025. Prashar is stepping down to pursue an external career opportunity. Following his resignation, he will also cease to be part of the Senior Management Personnel of Abbott India from the same date. Munish Prashar joined Abbott in 2020. Prior to his time at Abbott, he spent over six years at Reckitt. His professional journey spans several renowned companies, including Colgate-Palmolive India Limited, Hindustan Coca-Cola Beverages, Joyco India, and Vardhman Textiles. Read also:Abbott Dissolving Stent receives CE Mark in Europe for peripheral artery disease Headquartered in Mumbai, Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories The Company offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. Abbott India Limited is part of Abbott's global pharmaceutical business in India.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!